How to Read a Mushroom Study’s Disclosure Trail: A Field-Recording Worksheet

How to check a mushroom study’s disclosure trail

A mushroom study’s disclosure trail is the funding statement, conflict-of-interest statement, author affiliation list, and trial registry record that together show who paid for the research and who ran it. Most readers never locate all four. This worksheet is for finding and recording them, one paper at a time — not for judging whether the study is trustworthy.

That judgment call comes after the recording step, and it’s covered elsewhere on this site, linked throughout the sections below.

What this worksheet does not cover

Three other guides on this site already do related jobs well, and this page is built to send you to them rather than repeat them:

If you want to know whether a funding source predicts biased conclusions, see Research Funding and Industry Bias in Mushroom Science.
If you want to know who NIH, NCCIH, universities, and industry funders actually are, see Who Funds Mushroom Research?
If you want the full six-point checklist for judging a trial’s overall quality — sample size, blinding, control groups, and more — see How to Read a Mushroom Clinical Trial: A Consumer Guide.

This page assumes you’ve already decided a study is worth a closer look. Its only job is helping you find and log the disclosure trail itself.

The scenario: you have one study open right now

Say a mushroom press release cites a specific human trial on cognitive focus. You pull up the paper. Before you accept or dismiss anything it claims, there are four places to check, in this order: the funding statement, the conflict-of-interest statement, the author affiliation list, and the trial’s registry record. Each one answers a different question, and each one can be missing, vague, or contradicted by another. Recording all four, even briefly, is what turns a skim into an actual read.

Stop first if something urgent brought you here

If you’re trying to evaluate a study because you or someone else is having a reaction to a mushroom product, a supplement, or a suspected poisoning, this worksheet is not the resource you need right now. Call Poison Control at 1-800-222-1222 or seek emergency care first. Come back to disclosure-checking once the immediate situation is handled.

Where is the study’s funding statement?

Most journals require a statement, usually in a section labeled “Funding,” “Financial Support,” or similar, naming who paid for the research. It’s typically near the end of the article, sometimes in an “Acknowledgments” section rather than a standalone one.

What to write down: the exact name of every funder listed, not a paraphrase. “Funded by a mushroom extract manufacturer” and “Funded by [Company Name], which also holds a patent on the tested extract” are different facts, and only the second is something you can verify independently.

If no funding statement exists at all, record that too — a missing statement is itself a data point, not a neutral default.

What does the conflict-of-interest statement disclose?

This is a separate statement from the funding line, and papers can have one without the other. It’s where authors disclose personal financial ties — employment, consulting fees, stock, patents, honoraria — that go beyond who paid for the study itself. An author can work for a university (independent funding) while also consulting for the company whose product is being tested; the funding line won’t show that, but the conflict-of-interest statement should.

What to write down: for each author, any disclosed relationship to a company connected to the studied product, in their own words from the statement. If the statement says “the authors declare no competing interests,” record that exact phrase rather than assuming it means the same thing as “not paid by anyone.”

What do the author affiliations show?

This sits near the authors’ names, usually right under the title, and lists each author’s institutional home — a university department, a hospital, or a company. It’s easy to skip because it looks like formatting rather than information.

What to write down: whether any author’s listed affiliation is the company that makes or sells the product being studied, or a research institute the company funds directly. This can surface a connection that a thin or boilerplate conflict-of-interest statement doesn’t spell out.

How do you find and read the trial’s registry record?

This is the item the other guides on this site touch on but don’t walk through in detail, so it gets the most space here.

Randomized human trials are generally expected to be registered in a public registry before the first participant is enrolled. The International Committee of Medical Journal Editors (ICMJE) — the group whose recommendations set common practice across biomedical journals — requires registration “at or before the time of first patient consent for enrollment” as a condition for a journal to consider publishing the results. The registry can be ClinicalTrials.gov or a primary registry in the World Health Organization’s International Clinical Trials Registry Platform (WHO ICTRP) network; both are free to search, open to any legitimate trial, and run by not-for-profit or governmental bodies rather than by trial sponsors themselves.

Registration exists specifically to stop two things: researchers quietly changing which outcome they report after seeing the data (selective reporting), and multiple teams unknowingly duplicating the same trial. A registered trial has to specify its planned outcomes in advance, which lets you compare what a paper reports against what was originally promised.

How to find the record

Search ClinicalTrials.gov directly, or look inside the study itself for an “NCT number” (a code starting with “NCT” followed by digits) or a registration number from another registry, often listed in the abstract or methods section. Searching that number directly on ClinicalTrials.gov or the WHO ICTRP search portal will pull up the record if one exists.

What the record can tell you that the paper alone might not

A ClinicalTrials.gov record separates a few roles that are easy to blur together when you’re only reading the published paper:

Sponsor — the organization defined as the one that “initiates the study, by preparing and/or planning the study, and who has authority and control over the study.” This is often, but not always, the same entity that funded it.
Responsible party — whichever of the sponsor, a sponsor-investigator, or a principal investigator designated by the sponsor is accountable for the registry entry itself.
Collaborator — any other organization providing support, which the registry defines broadly enough to include funding, study design, data analysis, or reporting help, even if that organization isn’t the sponsor of record.

Why the sponsor and the company that funded the study aren’t always the same

It’s tempting to treat “sponsor” as a synonym for “funder,” but the registry doesn’t use them that way. A university can be listed as the sponsor because it designed and controls the study, while a supplement manufacturer appears separately as a collaborator because it paid for it or supplied the material being tested. Reading only the paper’s funding line can miss this split; reading the registry record shows both roles side by side.

What to write down: the registration number, the date it was registered relative to the study’s start date (registered before enrollment began, or after), the listed sponsor, the listed responsible party, and any collaborators. If you can’t find a registry record for what should have been a registered trial, or the registration date comes after the trial’s actual start, write that down as its own flag — late registration is one of the more concrete signs that outcomes may have been chosen after the fact rather than planned in advance.

What does a field-recording template look like?

For any single study you’re checking, work through these four items in order and write down what you find for each:

Funding statement says: _____ (or: none found)
Conflict-of-interest statement says: _____ (or: none found)
Author affiliations: _____ (any tie to the studied product’s maker?)
Registry record: number _____, registered (before / after / not found) enrollment, sponsor _____, responsible party _____, collaborators _____

Filling in “none found” or “not found” is a legitimate answer. The point of this worksheet is an honest record of what’s actually disclosed, not a search for a predetermined verdict.

What does a completed worksheet actually tell you?

A disclosed industry funder, a named conflict of interest, or an affiliation with the product’s manufacturer is a fact you now have on record — it is not proof the study’s conclusions are wrong. Independently funded studies can be poorly designed, and industry-funded studies can be rigorously run and registered on time. What the worksheet gives you is the raw material for that next-level judgment, which is exactly what the three linked guides above walk through: whether funding source correlates with biased outcomes, who the major funders in this field tend to be, and how to weigh disclosure alongside sample size, blinding, and outcome reporting as part of a study’s overall quality.

What should you do once the worksheet is filled in?

Once your worksheet is filled in, three simple questions organize what to do next:

Is everything disclosed and registered on time, with no ties between authors and the product’s maker? Treat the disclosure trail as clean, and move on to judging the study on its methods using the full quality checklist linked above.

Is something disclosed — a funder, a conflict, an affiliation — but registration happened before enrollment and the statements are specific and complete? The disclosure system worked as intended. Read the study’s methods more carefully, and weigh the disclosed relationship using the bias-focused guide linked above rather than dismissing the study outright.

Is something missing that should exist — no funding statement at all, no registry record for what looks like a randomized trial, or a registration date that comes after the study started? Treat that as a caution flag on its own, independent of whatever the study concludes, and weigh the paper accordingly.

What are this worksheet’s evidence limits?

Disclosure norms vary by journal, by country, and by publication date; older studies may predate current registration expectations entirely, which is a limitation of the norms themselves rather than evidence of concealment. Some legitimate early-phase or observational research is not required to be registered in the same way randomized trials are. This worksheet also can’t tell you whether a disclosure statement is complete or accurate — it can only help you locate what’s stated and note when something expected is absent.

Frequently asked questions

What if I can’t find a conflict-of-interest statement anywhere in the paper?

Record it as not found. Some older papers or some journals did not require a separate statement at the time of publication; that’s a limitation to note rather than something to guess about.

Does an industry funder automatically mean the study is unreliable?

No. A disclosed industry funder is one fact to record, not a verdict. See the bias-focused guide linked above for how funding source relates to outcomes across the broader research literature.

Is every mushroom study required to be registered?

Registration expectations mainly apply to randomized human trials intended for publication in journals that follow ICMJE-aligned policies. Preclinical research, and some observational or early-phase human research, isn’t held to the same registration requirement.

Where exactly do I search for a registry record?

ClinicalTrials.gov’s own search tool, using the NCT number if the paper lists one, or the study title and lead investigator’s name if it doesn’t. The World Health Organization’s International Clinical Trials Registry Platform search portal covers trials registered outside the U.S. system.

Is a study’s sponsor always the same as the company that paid for it?

No. The registry defines the sponsor as whichever organization initiates and controls the study, which is sometimes a university or research institute rather than the company that funded it or supplied the product. A funding company can instead appear as a collaborator, so the sponsor line and the funding line are worth recording separately rather than assumed to match.